News | March 19, 2014

ICPME Offers Molecular Breast Imaging CME Course

Nuclear Imaging Mammogrpahy Women's Health ICPME MBI Molecular Breast Imaging

March 19, 2014 — Molecular breast imaging (MBI) Clinical Indications, Benefits and Challenges is the focus of a new CME credit course to be offered by ICPME. It is funded in part by Gamma Medica Inc. and in part by GE Healthcare. The one-hour online session will provide a thorough overview of MBI, which is a growing imaging technology for women with dense breasts and certain difficult-to-image cancers.

Research has shown that for women with dense breasts, MBI technology outperformed mammography in finding more cancers. This makes MBI, which has the ability to detect breast cancer lesions as small as 5 mm, a highly effective secondary diagnostic tool. This is particularly true for women with dense breast tissue and who have inconclusive results on their initial mammograms.

MBI’s ability to detect smaller lesions lies in its ability to use molecular functional imaging, allowing for breast abnormalities to be detected based on altered characteristics of the tissue. Functional imaging is important for distinguishing between a viable and nonviable mass because functional changes precede anatomical changes in breast tissue.

The certified pre-recorded session is presented by Stephen W. Phillips, M.D., FACR, medical director of Methodist Sugar Land Hospital Breast Center (MSLH), assistant professor of radiology at Weill Cornell Medical College, New York, and formerly assistant professor of radiology at Mayo Clinic. Since 2012, Phillips has played a role in MBI clinical research at MSLH, where he currently utilizes MBI as a contributor to the general health and well-being of women in the greater Texas area.

The course assesses the role of MBI as a complementary tool to mammography, describes patient indications for use, evaluates MBI benefits and challenges and covers the counseling of patients with dense breast tissue. It is accredited for 1.0 AMA PRA Category 1 credit and participants can register on the ICPME.

For more information:

Related Content

Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...